['heart failure', 'respiratory insufficiency', 'stroke acute', 'infectious diseases', 'rheumatic diseases']
['rivaroxaban, 10 mg', 'rivaroxaban, 7.5 mg', 'placebo']

        Key Inclusion Criteria:

          -  The duration of the index hospitalization must have been at least 3 and no more than
             10 consecutive days

          -  Must meet venous thromboembolism (VTE) risk criteria with a total modified Improve VTE
             Risk Score of: greater than or equal 4, or 3 with D-dimer > 2* upper limit of normal
             (ULN), or 2 with D-dimer > 2*ULN

        Key Exclusion Criteria:

          -  Any serious bleeding within 3 months prior to randomization or occurring during index
             hospitalization

          -  Serious trauma (including head trauma) within 4 weeks before randomization

          -  History of hemorrhagic stroke at any time in the past

          -  Any medical condition that requires chronic use of any parenteral or oral
             anticoagulation
      